| 摘要 |
<p>The present invention relates to a lung cancer diagnostic composition comprising a Stannioncalcin-2 (STC-2) protein-specific antibody and a lung cancer diagnostic composition comprising a primer or a probe specific to a nucleic acid encoding the protein, as a biomarker useful to diagnose a lung cancer early. The lung cancer diagnostic marker of the present invention can be useful to diagnose a lung cancer early, and also, is useful to estimate a progress of a disease and a prognosis before and after a treatment.</p> |
